| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 866,379 | 843,393 | 867,874 | 984,258 | | Cost of Revenue | 688,000 | 679,361 | 721,273 | 818,333 | | | Gross Profit | 178,379 | 164,032 | 146,601 | 165,925 | | | Operating Expenses | | Research Development | 6,533 | 6,042 | 6,023 | 6,222 | | Selling General and Administrative | 92,052 | 88,755 | 79,976 | 85,782 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 79,794 | 69,235 | 60,602 | 73,921 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,564 | (4,564) | 1,379 | 8,028 | | Earnings Before Interest And Taxes | 84,358 | 64,671 | 60,742 | 80,005 | | Interest Expense | 5,861 | 6,023 | 9,037 | 10,242 | | Income Before Tax | 78,497 | 58,648 | 51,705 | 69,763 | | Income Tax Expense | 28,800 | 21,300 | 18,500 | 25,500 | | Minority Interest | 638 | (638) | (1,239) | (1,944) | | | | Net Income From Continuing Ops | 50,335 | 36,710 | 33,205 | 44,263 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 50,335 | 36,710 | 33,205 | 44,263 | | Preferred Stock And Other Adjustments | (1,814) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $48,521 | $36,710 | $33,205 | $44,263 |
|
2.03% Nasdaq 
Income Statement
